These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24867672)

  • 21. Bone histomorphometry and indicators of bone and mineral metabolism in wait-listed dialysis patients.
    Keronen S; Martola L; Finne P; Burton IS; Kauppila L; Kröger H; Larsson TE; Honkanen E
    Clin Nephrol; 2016 Mar; 85(3):127-34. PubMed ID: 26833298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone histomorphometry in renal osteodystrophy.
    Ott SM
    Semin Nephrol; 2009 Mar; 29(2):122-32. PubMed ID: 19371803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of bone mineral density measured by dual energy X-ray absorptiometry (DXA) and peripheral quantitative computed microtomography in chronic kidney disease.
    Jannot M; Mac-Way F; Lapierre V; Lafage-Proust MH
    J Nephrol; 2017 Oct; 30(5):635-643. PubMed ID: 28900872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
    Pimentel A; Ureña-Torres P; Zillikens MC; Bover J; Cohen-Solal M
    Kidney Int; 2017 Dec; 92(6):1343-1355. PubMed ID: 28964571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trabecular bone score may indicate chronic kidney disease-mineral and bone disorder (CKD-MBD) phenotypes in hemodialysis patients: a prospective observational study.
    Yun HJ; Ryoo SR; Kim JE; Choi YJ; Park I; Shin GT; Kim H; Jeong JC
    BMC Nephrol; 2020 Jul; 21(1):299. PubMed ID: 32711466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Micro-CT in the Assessment of Pediatric Renal Osteodystrophy by Bone Histomorphometry.
    Pereira RC; Bischoff DS; Yamaguchi D; Salusky IB; Wesseling-Perry K
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):481-7. PubMed ID: 26712809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone Biopsy Results in Chronic Kidney Disease: a Single-Center Experience.
    Liangos O; Kirchhoff S; Buchholz J; Ketteler M
    Kidney Blood Press Res; 2018; 43(4):1222-1230. PubMed ID: 30071519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Accuracy of Biomarkers and Imaging for Bone Turnover in Renal Osteodystrophy.
    Salam S; Gallagher O; Gossiel F; Paggiosi M; Khwaja A; Eastell R
    J Am Soc Nephrol; 2018 May; 29(5):1557-1565. PubMed ID: 29555831
    [No Abstract]   [Full Text] [Related]  

  • 30. Time to rethink the use of bone biopsy to prevent fractures in patients with chronic kidney disease.
    Steller Wagner Martins C; Jorgetti V; Moysés RMA
    Curr Opin Nephrol Hypertens; 2018 Jul; 27(4):243-250. PubMed ID: 29608453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone Turnover, Mineralization, and Volume Estimated by 18F-Sodium Fluoride PET/CT and Biomarkers in Chronic Kidney Disease: Mineral and Bone Disorder Compared with Bone Biopsy.
    Vrist MH; Østergaard AMH; Langaa SS; Mose FH; Fynbo CA; Theil J; Langdahl BL; Lauridsen TG; Bech JN
    Am J Nephrol; 2022; 53(6):490-502. PubMed ID: 35671711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating markers of bone turnover.
    Vervloet MG; Brandenburg VM;
    J Nephrol; 2017 Oct; 30(5):663-670. PubMed ID: 28502032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone disease in pediatric chronic kidney disease.
    Wesseling-Perry K
    Pediatr Nephrol; 2013 Apr; 28(4):569-76. PubMed ID: 23064662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteoporosis and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Back to Basics.
    Pazianas M; Miller PD
    Am J Kidney Dis; 2021 Oct; 78(4):582-589. PubMed ID: 33774081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum osteoprotegerin measurement for early diagnosis of chronic kidney disease-mineral and bone disorder.
    Jiang JQ; Lin S; Xu PC; Zheng ZF; Jia JY
    Nephrology (Carlton); 2011 Aug; 16(6):588-94. PubMed ID: 21649792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.
    Bover J; Bailone L; López-Báez V; Benito S; Ciceri P; Galassi A; Cozzolino M
    J Nephrol; 2017 Oct; 30(5):677-687. PubMed ID: 28432640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Updates in CKD-Associated Osteoporosis.
    Khairallah P; Nickolas TL
    Curr Osteoporos Rep; 2018 Dec; 16(6):712-723. PubMed ID: 30353319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone imaging and fracture risk assessment in kidney disease.
    Jamal SA; Nickolas TL
    Curr Osteoporos Rep; 2015 Jun; 13(3):166-72. PubMed ID: 25744703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Morphological analysis of bone dynamics and metabolic bone disease. Renal Osteodystrophy and New KDIGO CKD-MBD classification].
    Tsukamoto Y
    Clin Calcium; 2011 Apr; 21(4):593-7. PubMed ID: 21447928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series.
    Amerling R; Harbord NB; Pullman J; Feinfeld DA
    Blood Purif; 2010; 29(3):293-9. PubMed ID: 20090316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.